Research paperA decline in the prevalence of injecting drug users in Estonia, 2005–2009
Introduction
There is evidence that both risk behaviours (high risk sexual behaviour, illicit drug use) and related infectious diseases (sexually transmitted and blood borne infections) are constantly evolving in the interplay between social-environmental factors, pathogens and their hosts (Bello, Simwaka, Ndhlovu, Salaniponi, & Hallett, 2011). In an epidemic outbreak of an infectious disease the prevalence in a particular population does not grow indefinitely, but saturates at some level. Following the initial spread there is generally a fall in the incidence followed by a reduction in prevalence. The same is likely to apply to behavioral epidemics. There are similarities between the spread of drug use, in particular the spread of the use addictive drugs (such as heroin), and that of infectious diseases. The use of drugs is communicated, not as an organic agent, but as a kind of “innovative” social practice or custom, and not to everyone but only to those who, for whatever reason, are not immune (i.e., susceptible individuals) (Rossi, 2002).
Behavioural epidemics have received little attention compared with infectious disease epidemics in Eastern Europe.
Estonia is a small country in the northern–eastern part of Europe with a population of about 1,340,000 (Statistics Estonia, 2012). According to a global review of injection drug use and HIV epidemiology, Estonia has one of the highest prevalences of injection drug users (IDUs) among people aged 15–64 years (1.51% in 2007) coupled with a high HIV prevalence among IDUs (Mathers et al., 2008, Uusküla et al., 2008). We have previously estimated the prevalence of IDU among ages 15–44 in Estonia to be 2.4% in 2004 (Uusküla et al., 2007).
Capture–recapture (CRC) is an indirect method that estimates population size from the degree of overlap between two or more separate samples from a population (Hook & Regal, 1995). The method calculates the extent to which the same individuals appear in datasets from different sources, and extrapolates from this to estimate the number of individuals who do not appear in any of the sources. Several assumptions are made when using CRC: the population is closed; overlaps between datasets can accurately be identified; the samples are independent or multiple sources are used to account for dependencies; all members of the population have an equal probability of occurring in any of the sources; representative samples of the population can be obtained (Millar, Domingo-Salvany, Eastwood, & Hay, 2008). As injection drug use encompasses criminal and health problems, CRC studies should obtain data from both criminal justice and healthcare sources to target the population (Hickman, Seaman, & de Angelis, 2001).
We have used CRC methodology to estimate the number of IDUs in the 15–44 year age range in Estonia for each year between 2005 and 2009and to examine the trend in prevalence of injection drug users during this period.
Section snippets
Data sources and definitions
Our target population was men and women aged 15–44 who were residents in Estonia and injecting drugs at some time between 2005 and 2009. Series of cross-sectional studies conducted in several location and across the period of 2004–2011 have documented that overwhelming majority (∼95%) of IDUs in Estonia are of age 15–44 (Talu et al., 2010, Uusküla et al., 2012). We used four data sources: (1) police data on drug-related offences, (2) data on drug treatment from the Estonian Health Insurance
Results
The four capture sources are described in Table 2. Gender was not recorded in 0.3% of records in the POLIS database, and these were therefore excluded from the analyses. In the other data sets, full identification was possible for all records. Comparison of the ID variable with the databases’ own ID code revealed that 19 persons in the police and 4 persons in the EHIF data set had identical characteristics to another person but the database's inner ID indicated that they were different persons.
Discussion
This is the first study from Eastern Europe designed to describe the course of the injection drug users epidemic. There was a reduction in the estimated number of injection drug users over time. An estimated number of the injection drug users in Estonia were 15,675, 11,493 and 5362 for the years 2005, 2008 and 2009, accordingly. These estimates translate as a prevalence of IDUs among the population aged 15–44 in Estonia 2.7% (1.8–7.9%) in 2005 to 2.0% (1.4–5.0%) in 2008, and 0.9% (0.7–1.7%) in
Conclusions
The costs that illicit drugs impose on society are high and illicit drug use is notoriously difficult to control (Room and Reuter, 2012, Ryan, 1998). Research into the course of drug use epidemics and their drivers are important contributors to the knowledge needed to develop effective control interventions and policies.
This study, estimating IDU prevalence using CRC methodology documented a decrease in IDU prevalence over a 5-year period in Estonia. While acknowledging the limitations of the
Acknowledgements
The study was supported by the grant SF0180060s09 from the Estonian Ministry of Education and Research; by the R01 AI 083035 grant from the NIH (USA); and the EMCDDA Grant No. GA.12.RTX.007.1.0.
We thank Senior Inspector Ain Borodin and Chief Superintendent of the Police Work Department, Analysis and Planning Division Marilis Sepp; Ms Triin Tõrvand from the Estonian Health Insurance Fund; and the Head of the Estonian Causes of Death Registry Gleb Denissov for their valuable contributions.
References (43)
- et al.
Why present-oriented societies undergo cycles of drug epidemics
Journal of Economic Dynamics and Control
(2002) - et al.
Global epidemiology of injecting drug use and HIV among people who inject drugs: A systematic review
Lancet
(2008) - et al.
How well do international drug conventions protect public health?
Lancet
(2012) - et al.
HIV infection and risk behaviour of primary fentanyl and amphetamine injectors in Tallinn, Estonia: implications for intervention
International Journal of Drug Policy
(2010) - et al.
Multiple routes of drug administration and HIV risk among injecting drug users
Journal of Substance Abuse Treatment
(2012) - et al.
Evidence for changes in behaviour leading to reductions in HIV prevalence in urban Malawi
Sexually Transmitted Infections
(2011) - et al.
Discrete multivariate analysis: Theory and practice
(1975) Problems with using capture–recapture in epidemiology: An example of a measles epidemic
Journal of Clinical Epidemiology
(1999)Recent developments concerning the DRD Key Indicator in Estonia
- Des Jarlais D. C., Pinkerton S., Feelemyer J., Hagan H., Guardino V., Cooper H., et al. (2012). 30 Years on: Critical...